Literature DB >> 10583275

NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases.

L Mauvieux1, E Delabesse, P Bourquelot, I Radford-Weiss, A Bennaceur, G Flandrin, F Valensi, E A MacIntyre.   

Abstract

Expression of NG2 has been reported in the majority of paediatric acute leukaemia (AL) cases with MLL rearrangement. We demonstrated 7. 1 positivity in 2/3 paediatric and 4/11 adult MLL rearranged acute myeloid leukaemia (AML) but in 0/28 adult AML without MLL rearrangement, thus extending the 100% specificity to adult cases. Positivity correlated with stage of maturation arrest since it was found in 0/6 immature AML but in 6/8 monoblastic cases. These data demonstrate that, if NG2 expression in AL is the (in)direct result of MLL rearrangement, such activation is restricted to a monoblastic population in AML. They also have practical implications for NG2 diagnostic screening strategies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583275     DOI: 10.1046/j.1365-2141.1999.01730.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

1.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

Review 2.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

3.  Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Authors:  Le-Le Lu; Jing Sun; Jie-Juan Lai; Yan Jiang; Lian-Hua Bai; Lei-Da Zhang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias.

Authors:  Bruno A Lopes; Caroline Pires Poubel; Cristiane Esteves Teixeira; Aurélie Caye-Eude; Hélène Cavé; Claus Meyer; Rolf Marschalek; Mariana Boroni; Mariana Emerenciano
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

5.  MLL-ENL cooperates with SCF to transform primary avian multipotent cells.

Authors:  Cathleen E Schulte; Marieke von Lindern; Peter Steinlein; Hartmut Beug; Leanne M Wiedemann
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

6.  Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.

Authors:  Allison S Drake; Michael T Brady; Xin Hui Wang; Sheila J N Sait; Justin C Earp; Sampa Ghoshal Gupta; Soldano Ferrone; Eunice S Wang; Meir Wetzler
Journal:  Cancer Immunol Immunother       Date:  2008-08-02       Impact factor: 6.968

7.  The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.

Authors:  M Chekenya; C Krakstad; A Svendsen; I A Netland; V Staalesen; B B Tysnes; F Selheim; J Wang; P Ø Sakariassen; T Sandal; P E Lønning; T Flatmark; P Ø Enger; R Bjerkvig; M Sioud; W B Stallcup
Journal:  Oncogene       Date:  2008-05-12       Impact factor: 9.867

8.  NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.

Authors:  M Talal F Al-Mayhani; Richard Grenfell; Masashi Narita; Sara Piccirillo; Emma Kenney-Herbert; James W Fawcett; V Peter Collins; Koichi Ichimura; Colin Watts
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

9.  Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.

Authors:  Agnete Svendsen; Joost J C Verhoeff; Heike Immervoll; Jan C Brøgger; Justyna Kmiecik; Aurelie Poli; Inger A Netland; Lars Prestegarden; Jesús Planagumà; Anja Torsvik; Anneli Bohne Kjersem; Per Ø Sakariassen; Jan I Heggdal; Wouter R Van Furth; Rolf Bjerkvig; Morten Lund-Johansen; Per Ø Enger; Joerg Felsberg; Nicolaas H C Brons; Karl J Tronstad; Andreas Waha; Martha Chekenya
Journal:  Acta Neuropathol       Date:  2011-08-24       Impact factor: 17.088

10.  Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.

Authors:  Jian Wang; Agnete Svendsen; Justyna Kmiecik; Heike Immervoll; Kai Ove Skaftnesmo; Jesús Planagumà; Rolf Kåre Reed; Rolf Bjerkvig; Hrvoje Miletic; Per Øyvind Enger; Cecilie Brekke Rygh; Martha Chekenya
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.